Literature DB >> 31666340

Time for revival of the red blood cell count and red cell mass in the differential diagnosis between essential thrombocythemia and polycythemia vera?

Hans Carl Hasselbalch1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31666340      PMCID： PMC6821626          DOI： 10.3324/haematol.2019.229039

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  56 in total

Review 1.  Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?

Authors:  Barry S Coller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-01-20       Impact factor: 8.311

2.  Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis.

Authors:  Richard T Silver; William Chow; Attilio Orazi; Stephen P Arles; Stanley J Goldsmith
Journal:  Blood       Date:  2013-07-30       Impact factor: 22.113

3.  Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study.

Authors:  Marie Warny; Jens Helby; Henrik S Birgens; Stig E Bojesen; Børge G Nordestgaard
Journal:  J Thromb Haemost       Date:  2019-08-20       Impact factor: 5.824

Review 4.  Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.

Authors:  Elisa Rumi; Mario Cazzola
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

5.  Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

Authors:  Ayalew Tefferi; Juergen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Tiziano Barbui; Curtis A Hanson; Giovanni Barosi; Srdan Verstovsek; Gunnar Birgegard; Ruben Mesa; John T Reilly; Heinz Gisslinger; Alessandro M Vannucchi; Francisco Cervantes; Guido Finazzi; Ronald Hoffman; D Gary Gilliland; Clara D Bloomfield; James W Vardiman
Journal:  Blood       Date:  2007-05-08       Impact factor: 22.113

Review 6.  Myeloid cell contributions to cardiovascular health and disease.

Authors:  Matthias Nahrendorf
Journal:  Nat Med       Date:  2018-06-04       Impact factor: 53.440

7.  Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.

Authors:  Ayalew Tefferi; Tiziano Barbui
Journal:  Am J Hematol       Date:  2017-01       Impact factor: 10.047

Review 8.  The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.

Authors:  Tiziano Barbui; Jürgen Thiele; Heinz Gisslinger; Hans Michael Kvasnicka; Alessandro M Vannucchi; Paola Guglielmelli; Attilio Orazi; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2018-02-09       Impact factor: 11.037

Review 9.  Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis.

Authors:  Victor R Gordeuk; Nigel S Key; Josef T Prchal
Journal:  Haematologica       Date:  2019-03-14       Impact factor: 9.941

10.  JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

Authors:  Elisa Rumi; Daniela Pietra; Virginia Ferretti; Thorsten Klampfl; Ashot S Harutyunyan; Jelena D Milosevic; Nicole C C Them; Tiina Berg; Chiara Elena; Ilaria C Casetti; Chiara Milanesi; Emanuela Sant'antonio; Marta Bellini; Elena Fugazza; Maria C Renna; Emanuela Boveri; Cesare Astori; Cristiana Pascutto; Robert Kralovics; Mario Cazzola
Journal:  Blood       Date:  2013-12-23       Impact factor: 22.113
View more
  2 in total

1.  Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells.

Authors:  Julian Baumeister; Tiago Maié; Nicolas Chatain; Lin Gan; Barbora Weinbergerova; Marcelo A S de Toledo; Jörg Eschweiler; Angela Maurer; Jiri Mayer; Blanka Kubesova; Zdenek Racil; Andreas Schuppert; Ivan Costa; Steffen Koschmieder; Tim H Brümmendorf; Deniz Gezer
Journal:  Ann Hematol       Date:  2021-08-14       Impact factor: 4.030

2.  A Practical Approach to Polycythemia in the Outpatient Setting and Its Importance.

Authors:  Helda Souresho; Michael Mgerian; Suzanne Havican; Elizabeth Suniega; Carol Gambrill
Journal:  Cureus       Date:  2021-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.